Compare PAYO & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYO | AXGN |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | 2540 | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.2B |
| IPO Year | N/A | 2013 |
| Metric | PAYO | AXGN |
|---|---|---|
| Price | $7.10 | $39.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | $7.69 | ★ $42.33 |
| AVG Volume (30 Days) | ★ 5.5M | 1.5M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $7.15 | $20.57 |
| Revenue Next Year | $10.28 | $16.68 |
| P/E Ratio | $30.36 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $4.08 | $11.25 |
| 52 Week High | $7.67 | $46.95 |
| Indicator | PAYO | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 73.66 | 39.60 |
| Support Level | $7.07 | $38.80 |
| Resistance Level | $7.15 | $39.99 |
| Average True Range (ATR) | 0.04 | 2.43 |
| MACD | -0.07 | -0.81 |
| Stochastic Oscillator | 45.83 | 12.90 |
Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.